Case Study on Ayurvedic and Panchkarma Intervention for Chronic Kidney Disease in an Elderly Patient

Authors

  • Acharya Manish Director, Meditation Guru, Jeena Sikho Lifecare Limited, India Author
  • Gitika Chaudhary Senior Consultant, General Surgeon, BAMS, PGDIP, PGDGS, MS (Ayurveda), Jeena Sikho Lifecare Limited, India Author
  • Richa Senior Research officer and Consultant, BAMS, PGDIP, CICR, CAIM, CMW, Jeena Sikho Lifecare Limited, India Author
  • Suyash Pratap Singh Medical Superintendent, BAMS, PGDIP, DNYT, CCMC, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India Author
  • Manjeet Singh Consultant, BAMS, PGDIP, ACLS, CCDN, CICR, CAIM, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India Author
  • Pooja Consultant, BAMS, PGDIP, DAGO, Jeena Sikho Lifecare limited Hospital Derabassi, Punjab, India Author

DOI:

https://doi.org/10.48165/ajm.2025.8.02.12

Keywords:

Ayurveda, Panchkarma, Vataj Pandu, Vrikk Vikar, Chronic Kidney Disease (CKD), Glomerular Filtration Rate

Abstract

Chronic Kidney Disease (CKD) is a progressive disorder affecting kidney structure and function, often complicated by Type 2 Diabetes Mellitus (T2DM) and hypertension. Early stage CKD is frequently asymptomatic, and management can be challenging, particularly in resource-limited settings due to high costs and limited accessibility of conventional therapies. This case report presents a 67-year-old male patient with CKD, T2DM, and hypertension, treated at Jeena Sikho Lifecare Limited Hospital, Derabassi, India, using a personalized Ayurvedic regimen combined with Panchakarma therapies. Following 12 days of inpatient treatment, the patient demonstrated marked clinical improvements: drowsiness, pedal oedema, eye vision and urine got better. Vital parameters showed gradual stabilization, with body weight decreasing from 83 kg to 76 kg and blood pressure stabilizing from highs of 180/90 mmHg to 120/80 mmHg. Laboratory investigations indicated significant improvements, with hemoglobin increasing from 7.3 gm/dL to 10.0 gm/dL, urea decreasing from 280.12 mg/dL to 100 mg/dL, creatinine declining from 6.10 mg/ dL to 4.5 mg/dL, and total RBC count increasing from 2.61 Mill/Cumm to 3.54 Mill/ Cumm. Uric acid stabilized at 7.1 mg/dL. Renal function assessed by GFR improved, with global GFR from 14.2 to 19.8 ml/min. This case highlights the potential of Ayurveda as an effective, accessible, and affordable approach for managing CKD Stage IV and associated comorbidities, demonstrating improvements in symptoms, vitals, laboratory parameters, and kidney function over a short inpatient treatment period.

Downloads

Download data is not yet available.

References

Francis, A., Harhay, M. N., Ong, A., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., & Wanner, C. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nature Reviews Nephrology, April 3, 1–3.

Jadoul, M., Aoun, M., & Imani, M. M. (2024). The major global burden of chronic kidney disease. The Lancet Global Health, 12(3), e342–e343.

Duff, R., Awofala, O., Arshad, M. T., Lambourg, E., Gallacher, P., Dhaun, N., & Bell, S. (2024). Global health inequalities of chronic kidney disease: A meta-analysis. Nephrology Dialysis Transplantation, gfae048.

Bello, A. K., Okpechi, I. G., Levin, A., Ye, F., Damster, S., Arruebo, S., Donner, J. A., Caskey, F. J., Cho, Y., Davids, M. R., & Davison, S. N. (2024). An update on the global disparities in kidney disease burden and care across world countries and regions. The Lancet Global Health, 12(3), e382–e395.

Singh, A. K., Farag, Y. M., Mittal, B. V., Subramanian, K. K., Reddy, S. R., Acharya, V. N., Almeida, A. F., Channakeshavamurthy, A., Ballal, H. S., Issacs, P. G., et al. (2013). Epidemiology and risk factors of chronic kidney disease in India–results from the SEEK study. BMC Nephrology, 14, 1–10.

Rajapurkar, M. M., John, G. T., Kirpalani, A. L., Abraham, G., Agarwal, S. K., Almeida, A. F., Gang, S., Gupta, A., Modi, G., Pahari, D., & Pisharody, R. (2012). What do we know about chronic kidney disease in India: First report of the Indian CKD registry. BMC Nephrology, 13, 1–8.

Ubaid, M., Mobin, A., Manzoor, I., Rehan, M., & Qadri, Z. (2022). A study on etiology, clinical features and complications of chronic kidney disease patients. Pakistan Journal of Medical and Health Sciences, 16(10), 488.

Roy, M. P. (2020). Correlates of chronic kidney disease in India. SN Comprehensive Clinical Medicine, 2(11), 2230–2234.

Parameswaran, S. (2012). Chronic kidney disease in India. Health Sciences, 1(2), 1–9.

Kumar, V., Yadav, A. K., Sethi, J., Ghosh, A., Sahay, M., Prasad, N., Varughese, S., Parameswaran, S., Gopalakrishnan, N., Kaur, P., & Modi, G. K. (2022). The Indian chronic kidney disease (ICKD) study: Baseline characteristics. Clinical Kidney Journal, 15(1), 60–69.

Dattu, M. S., Kumar, E. K., Krishnamurthy, S., & Reddy, Y. V. (2016). Aetiology of chronic kidney disease in rural patients. Journal of Clinical and Scientific Research, 5(4), 221–224.

Abraham, G., Moorthy, A. V., & Aggarwal, V. (2006). Chronic kidney disease: A silent epidemic in Indian subcontinent—strategies for management. Journal of Indian Medical Association, 104(12), 689–691.

Agarwal, S. K., & Srivastava, R. K. (2009). Chronic kidney disease in India: Challenges and solutions. Nephron Clinical Practice, 111(3), c197c203.

Vijay, V., Ameta, T., Das, P., Sharma, D., Kumar, S., & Sharma. (2022). A case study of chronic kidney disease. doi:10.47223/irjay.2022.5506

Panda, A. K. (Year not given). Prevention and reduce the complications of chronic kidney diseases: A holistic health care approach.

Mishra, S., Dash, R., & Kumar, S. (2024). Chronic kidney disease in light of Ayurveda: A literary review on Vataj Pandu. International Journal of Ayurveda and Pharma Research, May 4, 65–68.

Dang, P., Badyal, S., Dhawan, P., & Tiwari, H. S. International Ayurvedic Medical Journal.

Khan, K., & Padyana, S. (2024). Diabetic nephropathy: Ayur-nutri-pharmaco approach. Food Safety and Health.

Maurya, H. A., & Kumar, T. (2016). A review on comprehensive overview in the management of nephrotic disorders. Journal of Critical Reviews, 3(2), 34–43.

Acharya, M., Chaudhary, G., Singh, S. P., Singh, M., & Richa, R. (2013). Clinical evaluation of chronic kidney disease management: Integrating lifestyle modification and Ayurveda. International Journal of AYUSH, 10. doi:10.22159/prl.ijayush.v2013i10.1152

Indushree, B. S., & Kulkarni, V. (2021). Conceptual study on Madhutailika Basti – A review. World Journal of Pharmaceutical and Life Sciences, 7(6), 63–66.

Dukare, P., Gandhi, S., Shinde, S. T., & Patil, R. Matra Basti: A review.

Pandey, A., Azad, A. S., Bhardwaj, A., Thakur, G., & Prakash, G. M. Shridhar University, Dayanand Ayurvedic College.

Verma, J., & Gopesh, M. (2019). Udvartana (Ayurveda powder massage): A review article. International Journal of Innovative Science and Research Technology, 4(5), 1–10.

Shyam, B., Kulkarni, V., & Suttagati, S. M. (2022). A critical review on the concept of Udvarthana. International Journal of Panchakarma Research, 1–10.

G. R. A., Das, C. R., Ganesha, B. U., & Chaturvedi, A. (2022). A clinical application on Abhyanga (Indian classical massage therapy) – An overview. International Ayurvedic Medical Journal. doi:10.46607/iamj3410012022

Sharma, S., Vedpathak, S., Kumar, V., & Patidar, A. (2022). Review article on Sarvang Abhyang and Swedan. International Research Journal of Ayurveda and Yoga, 5(5), 144–147. doi:10.47223/IRJAY.2022.5523

Gopinathan, G., & Dhiman, K. S. (2013). Triphala in eye diseases: A critical review. Journal of Homeopathy & Ayurvedic Medicine, 2(123).

Firdouse, Z., & Katti, A. (2022). Significance of selection of ghrita in netra tarpana. 16(2), 183.

Yadav, K., Sharma, G. P., & Sharma, M. (2023). A review on netra tarpana – A special eye therapy. International Ayurvedic Medical Journal, April.

Joshwa, B., Khakha, D. C., & Mahajan, S. (2012). Fatigue, depression and sleep problems among hemodialysis patients in a tertiary care center. Saudi Journal of Kidney Diseases and Transplantation, 23(4), 729–735. doi:10.4103/1319-2442.98149

Brodovicz, K. G., McNaughton, K., Uemura, N., Meininger, G., Girman, C. J., & Yale, S. H. (2009). Reliability and feasibility of methods to quantitatively assess peripheral edema. Clinical Medicine Research, 7(1–2), 21–31. doi:10.3121/cmr.2009.819

Binsha, S., et al. (2020). Diabetes induced microalbuminuria – A critical review. International Ayurvedic Medical Journal.

Dang, P., et al. (2024). Chronic kidney disease (CKD) pathogenesis in Ayurveda parlance – A review. International Ayurvedic Medical Journal.

Kulkarni, A. N., & Kulkarni, R. A. (2023). Applying Ayurvedic principles for diagnosis and treatment of chronic kidney diseases: An integrative approach. International Journal of Scientific Research, 12(7).

Gangwal, V. A., & Neralkar, U. K. (2017). Role of dosha, dushya, strotas in samprapti of hypertension with an Ayurvedic perspective. International Ayurvedic Medical Journal.

Sidar, V., Ratre, G. R., & Bhagat, P. (2023). Role of pathya & apathya in madhumeha: A review. World Journal of Pharmaceutical and Medical Research, 9(1), 48–52.

Bhat, P., Nagaratna, S. J., Puranik, P., Sharashchandra, Chithralekha, & Kavya. (2021). Role of diet and lifestyle modification in hypertension: A complication of childhood obesity. Journal of Ayurveda and Integrated Medical Sciences, 6(6).

Schrauben, S. J., Apple, B. J., & Chang, A. R. (2022). Modifiable lifestyle behaviors and CKD progression: A narrative review. Kidney360, 3(4), 752–778. doi:10.34067/KID.0003122021

Guthrie, B. (2020). Can NSAIDs be used safely for analgesia in patients with CKD?: CON. Kidney360, 1(11), 1189–1191. doi:10.34067/KID.0005112020

Bruce, M. A., Griffith, D. M., & Thorpe, R. J. Jr. (2015). Stress and the kidney. Advances in Chronic Kidney Disease, 22(1), 46–53. doi:10.1053/j.ackd.2014.06.008

Gautam, S., & Kiran, U. V. (2024). Clinical effects of yoga and meditational practices on the holistic health of chronic kidney disease patients: A systematic review. Cureus, 16(4), e57546. doi:10.7759/cureus.57546

Aggarwal, A., Sokiya, G., & Sharma, G. (2023). Management of chronic kidney disease – An Ayurveda case study. Journal of Ayurveda and Integrated Medical Sciences, 8, 250–256. doi:10.21760/jaims.8.7.46

Agrawal, P., Singh, B. R., Gajbe, U., Kalambe, M. A., & Bankar, M. (2023). Managing diabetes mellitus with millets: A new solution. Cureus, 15(9), e44908. doi:10.7759/cureus.44908

Rafieian-Kopaei, M., Motamedi, P., Vakili, L., Dehghani, N., Kiani, F., Taheri, Z., Torkamaneh, S., Nasri, P., & Nasri, H. (2014). Green tea and type 2 diabetes mellitus. Journal of Nephropharmacology, 3(1), 21–23.

Sagar, P. S., Munt, A., Saravanabavan, S., Vahedi, F. A., Elhindi, J., Nguyen, B., Chau, K., Harris, D. C., Lee, V., Sud, K., Wong, N., & Rangan, G. K. (2023). Efficacy of beetroot juice on reducing blood pressure in hypertensive adults with autosomal dominant polycystic kidney disease (BEET-PKD). Trials, 24(1), 482. doi:10.1186/s13063-023-07519-2

Joshi, A. M., Raveendran, A. V., & Arumugam, M. (2024). Therapeutic role of yoga in hypertension. World Journal of Methodology, 14(1), 90–127. doi:10.5662/wjm.v14.i1.90127

Mallamaci, F., Pisano, A., & Tripepi, G. (2020). Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial. Nephrology Dialysis Transplantation, 35(Suppl 2), ii18–ii22. doi:10.1093/ndt/gfaa012

Park, J., Lyles, R. H., & Bauer-Wu, S. (2014). Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease. American Journal of Physiology, 307(1), R93–R101. doi:10.1152/ajpregu.00558.2013

Salifu, I., Tedla, F., Pandey, A., Ayoub, I., Brown, C., McFarlane, S. I., & Jean-Louis, G. (2014). Sleep duration and chronic kidney disease. Cardiorenal Medicine, 4(3–4), 210–216. doi:10.1159/000368205

Santhosh, S., Pazhani, G. P., Arathi, M. S., & Manickam, S. (2023). Nephroprotective role of Boerhavia diffusa in renal disorders: A review. Research Journal of Pharmacy and Technology, 16(2), 962–968. doi:10.52711/0974-360X.2023.00161

Meher, S. K., Mukherjee, P. K., Banarjee Chaudhury, S. K., Marjit, B., & Shaw, B. P. (2016). Experimental studies on the renal protective effect of Gokshura and Varuna. Research Journal of Pharmacology and Pharmacodynamics, 8(2), 75–82. doi:10.5958/2321-5836.2016.00014.8

Gupta, A., Gupta, P., & Bajpai, G. (2024). Tinospora cordifolia (Giloy): An insight on multifarious pharmacological paradigms. Heliyon, 10(4), e26125. doi:10.1016/j.heliyon.2024.e26125

Selvakumar, G., Shathirapathiy, G., Jainraj, R., & Yuvaraj, P. P. (2017). Immediate effect of bitter gourd, ash gourd, knol-khol juices on blood sugar levels. Journal of Traditional and Complementary Medicine, 7(4), 526–531. doi:10.1016/j.jtcme.2017.01.009

Agrawal, O. D., & Kulkarni, Y. A. (2023). Treatment with Terminalia chebula extract reduces insulin resistance. Life (Basel), 13(5), 1168. doi:10.3390/life13051168

Vasant, R. A., & Narasimhacharya, A. V. (2012). Amla as an antihyperglycemic and hepato-renal protective agent. Journal of Pharmacy and Bioallied Sciences, 4(3), 250–254. doi:10.4103/0975-7406.99067

Trivedi, N., Mazumdar, B., Bhatt, J., & Hemavathi, K. G. (2004). Effect of shilajit on blood glucose and lipid profile. Indian Journal of Pharmacology, 36(6).

Veisi, P., Zarezade, M., Rostamkhani, H., & Ghoreishi, Z. (2022). Renoprotective effects of ginger on diabetic kidney disease: A systematic review. BMC Complementary Medicine and Therapies, 22(1), 291. doi:10.1186/s12906-022-03768-x

Patange, V. (2011). A study on the effect of Kutaki on hypertension. International Journal of Ayurvedic Medicine, 2. doi:10.47552/ijam.v2i1.69

Downloads

Published

2025-12-09

How to Cite

Case Study on Ayurvedic and Panchkarma Intervention for Chronic Kidney Disease in an Elderly Patient . (2025). Academia Journal of Medicine, 8(2), 60-78. https://doi.org/10.48165/ajm.2025.8.02.12